Carl Icahn slams Illumina Q1 results and cost-cutting plan
Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016. David A. Grogan | CNBC Carl Icahn on Friday called Illumina’s first-quarter results “very disappointing” and slammed…
Carl Icahn speaking at Delivering Alpha in New York on Sept. 13, 2016. David A. Grogan | CNBC Carl Icahn on Friday called Illumina’s first-quarter results “very disappointing” and slammed…
Merck on Thursday reported first-quarter revenue and adjusted earnings that topped Wall Street’s expectations, despite a steep drop in sales of its Covid antiviral treatment molnupiravir. Sales of molnupiravir plunged to…
Johnson & Johnson logo SOPA Images | LightRocket | Getty Images Johnson & Johnson‘s consumer health business is valued at $40 billion ahead of its initial public offering later this…
The Abbott manufacturing facility in Sturgis, Michigan, on May 13, 2022. Jeff Kowalsky | AFP | Getty Images Shares of Abbott Laboratories popped Wednesday after the company’s earnings and revenue…
Johnson & Johnson shares fell Tuesday after the company reported adjusted earnings and revenue that topped Wall Street’s expectations, but lowered its sales guidance for its pharmaceutical business. J&J, whose financial…